MedPath

Comparative study to compare non invasive device with an invasive device to measure hemoglobin values for guiding in blood transfusion in major oncosurgeries

Not Applicable
Conditions
Health Condition 1: C00-D49- Neoplasms
Registration Number
CTRI/2021/03/031716
Lead Sponsor
Dr Ram Manohar Lohia Institute of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Patients consent

2. BMI <30

3. Hemoglobin level >10 gm/dl in Pre-Anesthetic Assessment

4.Patient posted for elective abdominal oncosurgery.

Exclusion Criteria

1. Patient refusal to give consent

2. Age <18years and >60 years

3. Patient suffering from cardiac pathology, documented peripheral vascular disease and

haemoglobinopathies

4. BMI >30

5. Hemoglobin <10gm/dl in Pre-Anesthetic Assesment.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To compare haemoglobin values between Non invasive Continuous Hemoglobin monitor and Quantitative Point Of Care Whole Blood Hemoglobin Monitor in major oncosurgery for guiding blood transfusionTimepoint: Invasive Hemoglobin monitoring will be used to obtain hemoglobin values at baseline (immediate preoperative),intraoperative (at every 30 minutes & sudden excessive blood loss) and immediate postoperative . <br/ ><br>Continuous Non invasive Hb monitoring will be done continuously
Secondary Outcome Measures
NameTimeMethod
1. To compare the number of units of blood transfused during intraoperative period. <br/ ><br>2. To assess the hemodynamic changes intra operativelyTimepoint: Every 30 minutes Intraoperatively
© Copyright 2025. All Rights Reserved by MedPath